At this time, only Saxenda, Wegovy, Zepbound and a small number of other weight-loss drugs (Contrave, Xenical, Alli, Qsymia and Imcivree) have been approved by the FDA for long-term use in weight management
Getting Started Eligibility: Standard criteria apply regardless of sex: BMI 30 or higher, OR BMI 27 or higher with a weight-related condition (hypertension, diabetes, sleep apnea, etc.) Accessing treatment: Options include: Primary care physicians Endocrinologists or obesity medicine specialists Telehealth platforms like TrimRx Cost considerations: Brand-name Ozempic/Wegovy: $349/month through manufacturer cash-pay programs Compounded semaglutide: $199/month through TrimRx For detailed cost information, see our guide on compounded semaglutide costs
Most providers recommend starting tirzepatide about one week after your last semaglutide dosetypically on your next scheduled injection day
And the results medications are used without support, short-term wins followed by long-term costs
VRK2 overexpression induced an increase in the expression of SLC7A11 at the PM level but not at the whole cell level
The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the PDQ Adult Treatment Editorial Board